©The Author(s) 2024.
World J Gastroenterol. Sep 14, 2024; 30(34): 3883-3893
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3883
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3883
Table 1 Risk factors of patients with erosive esophagitis at Tikur Anbesa specialized hospital and Adera medical and surgical center during the study period
| Risk factors | Number (n) | Percentage (%) | |
| BMI | Less than 18.5 | 13/221 | 5.9 |
| 18.5-24.9 | 114/221 | 51.6 | |
| 24.9-29.9 | 75/221 | 33.9 | |
| 30 and above | 19/221 | 8.6 | |
| Risk factor history | Family history present | 39/221 | 17.6 |
| Symptoms during pregnancy | 2/84 | 2.4 | |
| Traditional herb use | 18/221 | 8.1 | |
| Myotomy for Achalasia | 1/221 | 0.5 | |
| Smoking | Current smoker | 11/221 | 5% |
| Ex-smoker | 8/221 | 3.6 | |
| Alcohol | Occasional | 49/221 | 22.2 |
| More than 1 drink/week | 28/221 | 12.7 | |
| Drug history | CCB | 27/221 | 12.2 |
| Aspirin/NSAID | 13/221 | 5.9 | |
| Prednisolone | 4/221 | 1.8 | |
| Metformin | 4/221 | 1.8 | |
| Iron | 2/221 | 0.9 | |
- Citation: Mengistie FA, Shewaye AB, Tasamma AT, Ayalew ZS. Clinical features of gastroesophageal reflux disease and erosive esophagitis: Insights from patients undergoing esophagogastroduodenoscopy in resource-limited Ethiopia. World J Gastroenterol 2024; 30(34): 3883-3893
- URL: https://www.wjgnet.com/1007-9327/full/v30/i34/3883.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i34.3883